Literature DB >> 24859107

Improving treatment for opioid dependence: a perspective from the Ohio Valley node of the NIDA Clinical Trials Network.

Erin L Winstanley, Greg S Brigham, Dean Babcock, Theresa Winhusen.   

Abstract

PROBLEM: Rates of adoption of evidenced-based practices, including the use of medications, to treat opioid dependence are low and severely limit secondary prevention efforts to curtail the prescription drug epidemic.
PURPOSE: The goal of this article was to describe how involvement in a research clinical trials network (CTN) facilitated the adoption of medications to treat opioid dependence at two community-based treatment programs (CTPs) affiliated with the Ohio Valley Node (OVN) of the National Institute on Drug Abuse's (NIDA) CTN. KEY POINTS: Participation in a CTN may facilitate adoption by providing the infrastructure for trialability and observability, but the most critical function may be the knowledge translation that occurs through the individual-level professional relationships that develop.
CONCLUSION: Community-based treatment providers' involvement in research networks may increase the rate of evidence-based practice (EBP) adoption and improve outcomes for patients with opioid dependence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24859107      PMCID: PMC4209398          DOI: 10.1353/cpr.2014.0002

Source DB:  PubMed          Journal:  Prog Community Health Partnersh        ISSN: 1557-0541


  26 in total

1.  Disseminating innovations in health care.

Authors:  Donald M Berwick
Journal:  JAMA       Date:  2003-04-16       Impact factor: 56.272

2.  Availability of addiction medications in private health plans.

Authors:  Constance M Horgan; Sharon Reif; Dominic Hodgkin; Deborah W Garnick; Elizabeth L Merrick
Journal:  J Subst Abuse Treat       Date:  2007-05-17

3.  Innovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.

Authors:  Lori J Ducharme; Hannah K Knudsen; Paul M Roman; J Aaron Johnson
Journal:  J Subst Abuse Treat       Date:  2007-02-22

4.  Adoption and implementation of medications in addiction treatment programs.

Authors:  Hannah K Knudsen; Amanda J Abraham; Paul M Roman
Journal:  J Addict Med       Date:  2011-03       Impact factor: 3.702

Review 5.  A guiding framework and approach for implementation research in substance use disorders treatment.

Authors:  Laura J Damschroder; Hildi J Hagedorn
Journal:  Psychol Addict Behav       Date:  2011-06

6.  Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.

Authors:  Steve Martino; Gregory S Brigham; Christine Higgins; Steve Gallon; Thomas E Freese; Lonnetta M Albright; Eric G Hulsey; Laurie Krom; Susan A Storti; Harold Perl; Cathrine D Nugent; Denise Pintello; Timothy P Condon
Journal:  J Subst Abuse Treat       Date:  2010-06

7.  Using buprenorphine short-term taper to facilitate early treatment engagement.

Authors:  Gregory S Brigham; Leslie Amass; Theresa Winhusen; Judy M Harrer; Alvin Pelt
Journal:  J Subst Abuse Treat       Date:  2006-12-08

Review 8.  Efficacy of maintenance treatment with naltrexone for opioid dependence: a meta-analytical review.

Authors:  Björn Axel Johansson; Mats Berglund; Anna Lindgren
Journal:  Addiction       Date:  2006-04       Impact factor: 6.526

9.  Opioid treatment programs in the Clinical Trials Network: representativeness and buprenorphine adoption.

Authors:  Lori J Ducharme; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2008-11-11

Review 10.  Improving public health through access to and utilization of medication assisted treatment.

Authors:  Thomas F Kresina; Robert Lubran
Journal:  Int J Environ Res Public Health       Date:  2011-10-24       Impact factor: 3.390

View more
  2 in total

1.  Barriers to implementation of opioid overdose prevention programs in Ohio.

Authors:  Erin L Winstanley; Angela Clark; Judith Feinberg; Christine M Wilder
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

2.  Patient engagement, treatment preferences and shared decision-making in the treatment of opioid use disorder in adults: a scoping review protocol.

Authors:  Tyler Marshall; Elizabeth N Kinnard; Myles Hancock; Susanne King-Jones; Karin Olson; Adam Abba-Aji; Katherine Rittenbach; Sunita Vohra
Journal:  BMJ Open       Date:  2018-10-17       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.